Radiation dosimetric and biodistribution comparison of the PSMA agonists 177Lu-PSMA I&T, 99mTc-Hynic PSMA and 99Tc-PSMA I&T to the 177Lu-RM2 antagonist

被引：0
|
作者：
Limouris, G. [1 ,2 ]
Paphiti, M. [3 ]
Zafeirakis, A. [2 ]
机构：
[1] Natl & Kapodistrian Univ Athens, Sch Med, Nucl Med, Athens, Greece
[2] Army Share Fund Hosp Athens, Dept Nucl Med, Athens, Greece
[3] Pharmazac SA, Cyclotron Sect, Athens, Greece
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2023年 / 50卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
EP-0071
引用
收藏
页码：S459 / S459
页数：1
相关论文
共 50 条
  • [1] Radiochemical Stability of therapeutic radiopharmaceutical of 177Lu-PSMA I&T
    Chandrashekar, R.
    Fagan, J.
    Lim, R.
    Vyas, M.
    INTERNAL MEDICINE JOURNAL, 2022, 52 : 41 - 41
  • [2] Comparative preclinical biodistribution, dosimetry and endoradiotherapy in mCRPC of 177Lu-rhPSMA-7.3 and 177Lu-PSMA I&T
    Yusufi, N.
    Nekolla, S.
    Wurzer, A.
    Herz, M.
    D'Alessandria, C.
    Weber, W.
    Wester, H. J.
    Eiber, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S642 - S643
  • [3] Stability Matters: Radiochemical Stability of Therapeutic Radiopharmaceutical 177Lu-PSMA I&T
    Vyas, Madhusudan
    Lim, Remy
    Fagan, Jessica
    Chandrashekar, Rudresh
    JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2022, 50 (03) : 244 - 247
  • [4] Improved therapeutic index with the novel PSMA-ligand 177Lu-rhPSMA-10.1 compared to 177Lu-PSMA I&T - an intrapatient comparison
    Rinscheid, Andreas
    Dierks, Alexander
    Kircher, Malte
    Pfob, Christian
    Wengenmair, Hermann
    Wienand, Georgine
    Lapa, Constantin
    Janzen, Tilman
    Bundschuh, Ralph
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64
  • [5] Improved quality control of [177Lu]Lu-PSMA I&T
    Kraihammer, Martin
    Garnuszek, Piotr
    Bauman, Andreas
    Maurin, Michael
    Lafont, Manuel Alejandre
    Haubner, Roland
    von Guggenberg, Elisabeth
    Gabriel, Michael
    Decristoforo, Clemens
    EJNMMI RADIOPHARMACY AND CHEMISTRY, 2023, 8 (01)
  • [6] Improved quality control of [177Lu]Lu-PSMA I&T
    Martin Kraihammer
    Piotr Garnuszek
    Andreas Bauman
    Michael Maurin
    Manuel Alejandre Lafont
    Roland Haubner
    Elisabeth von Guggenberg
    Michael Gabriel
    Clemens Decristoforo
    EJNMMI Radiopharmacy and Chemistry, 8
  • [7] PSMA Radioligand Therapy of Metastasized Prostate Cancer Using Lu-177 PSMA I&T and Lu-177 PSMA-617: First comparative Dosimetric Results
    Schuchardt, C.
    Kulkarni, H. R.
    Wiessalla, S.
    Shahinfar, M.
    Singh, A.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S36 - S37
  • [8] Quantifying the impact of residual activity on therapeutic index: an updated dosimetric comparison between [177Lu]Lu-PSMA-10.1 and [177Lu]Lu-PSMA I&T
    Rinscheid, A.
    Dierks, A.
    Kircher, M.
    Pfob, C.
    Bundschuh, R. A.
    Lapa, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S811 - S812
  • [9] PSMA Radioligand Therapy (PRLT) using Lu-177 PSMA I&T and Lu-177 PSMA-617: Intra-individual comparison of kinetics and dosimetry
    Schuchardt, C.
    Kulkarni, H. R.
    Wiessalla, S.
    Shahinfar, M.
    Singh, A.
    Baum, R. P.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S214 - S214
  • [10] Patient dosimetry of 177Lu-PSMA I&T in metastatic prostate cancer treatment: the experience in Thailand
    Kotchakorn Chatachot
    Shuichi Shiratori
    Tawatchai Chaiwatanarat
    Kitiwat Khamwan
    Annals of Nuclear Medicine, 2021, 35 : 1193 - 1202
12345